Coppell Advisory Solutions LLC Alkermes Plc. Transaction History
Coppell Advisory Solutions LLC
- $716 Billion
- Q4 2024
A detailed history of Coppell Advisory Solutions LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 467 shares of ALKS stock, worth $15,602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
467
Previous 467
-0.0%
Holding current value
$15,602
Previous $12.9 Million
4.53%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
376Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$972 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$618 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$409 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$295 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$253 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.49B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...